The Use of MEK Inhibitors in...

The Oncologist 2020 / 04

The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities

Klesse, Laura J., Jordan, Justin T., Radtke, Heather B., Rosser, Tena, Schorry, Elizabeth, Ullrich, Nicole, Viskochil, David, Knight, Pamela, Plotkin, Scott R., Yohay, Kaleb
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2020-0069
Date:
April, 2020
File:
PDF, 1.40 MB
2020
Conversion to is in progress
Conversion to is failed